Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy

por Santich, Brian H., Cheung, Nai-Kong V., Klein, Christian
Publicado 2020

Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors

por Cheng, Ming, Santich, Brian H., Xu, Hong, Ahmed, Mahiuddin, Huse, Morgan, Cheung, Nai-Kong V.
Publicado 2016

Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

por Park, Jeong A, Santich, Brian H, Xu, Hong, Lum, Lawrence G, Cheung, Nai-Kong V
Publicado 2021

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

por Goswami, Meghali, Prince, Gabrielle, Biancotto, Angelique, Moir, Susan, Kardava, Lela, Santich, Brian H., Cheung, Foo, Kotliarov, Yuri, Chen, Jinguo, Shi, Rongye, Zhou, Huizhi, Golding, Hana, Manischewitz, Jody, King, Lisa, Kunz, Lauren M., Noonan, Kimberly, Borrello, Ivan M., Smith, B. Douglas, Hourigan, Christopher S.
Publicado 2017

Alpha radioimmunotherapy using (225)Ac-proteus-DOTA for solid tumors - safety at curative doses

por Cheal, Sarah M., McDevitt, Michael R., Santich, Brian H., Patel, Mitesh, Yang, Guangbin, Fung, Edward K., Veach, Darren R., Bell, Meghan, Ahad, Afruja, Vargas, Daniela Burnes, Punzalan, Blesida, Pillarsetty, Naga Vara Kishore, Xu, Hong, Guo, Hong-fen, Monette, Sébastien, Michel, Adam O., Piersigilli, Alessandra, Scheinberg, David A., Ouerfelli, Ouathek, Cheung, Nai-Kong V., Larson, Steven M.
Publicado 2020